Listed

AIM ImmunoTech Inc.

AIMNYSECIK 946644HealthcareFiscal year ends Dec 31

Reports and events: 417 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

AIM ImmunoTech Inc., Reports and events
FiledFormWhat it isAccession number
2019-10-0706:40 ET8-K2.02 Results of operations; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-19-015112
2019-09-2717:00 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-19-014689
2019-09-2520:32 ETS-1/ARegistration statement, amended0001493152-19-014528
2019-09-2415:37 ETS-1/ARegistration statement, amended0001493152-19-014486
2019-09-2406:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-19-014466
2019-09-2418:59 ETS-1/ARegistration statement, amended0001493152-19-014454
2019-09-1606:50 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-19-014139
2019-09-0906:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-19-013838
2019-09-0617:01 ETS-1Registration statement0001493152-19-013823
2019-08-2617:04 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-19-013386
2019-08-2308:00 ET8-K5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-19-013294
2019-08-2016:30 ETDEF 14AProxy statementPeriod 2019-08-200001493152-19-013142
2019-08-1416:31 ET10-QQuarterly reportPeriod 2019-06-300001493152-19-012572
2019-07-2213:46 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-19-010919
2019-06-2816:05 ETSC 13DOwnership report, active investor0001493152-19-009885
2019-06-2810:51 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-19-009853
2019-06-1816:04 ETSC 13D/AOwnership report, active investor, amended0001493152-19-009371
2019-06-0519:05 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-19-008701
2019-05-3112:04 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-19-008454
2019-05-1516:06 ET10-QQuarterly reportPeriod 2019-03-310001493152-19-007385
2019-05-0208:56 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-19-006271
2019-04-2417:35 ETDEF 14AProxy statementPeriod 2019-04-240001493152-19-005800
2019-04-0913:51 ETSC 13DOwnership report, active investor0001493152-19-005045
2019-04-0117:07 ET10-KAnnual reportPeriod 2018-12-310001493152-19-004583
2019-03-1520:13 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-19-003394
2019-03-0815:14 ET8-K5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-19-003021
2019-02-2708:55 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-19-002649
2019-02-1110:09 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-19-001665
2019-02-0718:18 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-19-001486
2019-02-0617:04 ETS-1/ARegistration statement, amended0001493152-19-001474
2018-12-2717:24 ETS-1Registration statement0001493152-18-018009
2018-12-1116:14 ET8-K1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001493152-18-017324
2018-11-1416:43 ET10-QQuarterly reportPeriod 2018-09-300001493152-18-016149
2018-10-2208:45 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-18-014710
2018-10-1018:26 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-18-014288
2018-10-0420:39 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-18-014063
2018-09-1316:15 ET8-K5.07 Shareholder vote results0001493152-18-013200
2018-08-1417:01 ET10-QQuarterly reportPeriod 2018-06-300001493152-18-011876
2018-08-0316:21 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-18-010947
2018-08-0306:15 ETDEF 14AProxy statementPeriod 2018-08-030001493152-18-010893
2018-07-2016:32 ETS-1/ARegistration statement, amended0001493152-18-010275
2018-07-0217:29 ETS-1Registration statement0001493152-18-009591
2018-05-1516:06 ET10-QQuarterly reportPeriod 2018-03-310001493152-18-007053
2018-05-0208:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-18-006106
2018-04-2017:29 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-18-005575
2018-04-1716:05 ET8-K5.02 Departure or appointment of officers or directors0001493152-18-005320
2018-04-0618:28 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001493152-18-004844
2018-03-3017:23 ET10-KAnnual reportPeriod 2017-12-310001493152-18-004291
2018-03-2206:06 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-18-003734
2018-03-1916:09 ET8-K/A1.01 Entry into a material agreement0001493152-18-003570

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:22 ET. Listed shows no prices and gives no investment advice.